News | December 25, 2025
Tanabe Pharma America transfers RADICAVA business to Shionogi
U.S. and Canada transaction supports continued access to RADICAVA for people living with ALS
U.S. and Canada transaction supports continued access to RADICAVA for people living with ALS
Provides pain relief for more than 30 conditions, including chronic back pain, arthritis, and sports injuries
If approved, imlifidase has the potential to transform the kidney transplant landscape by enabling highly sensitized patients to also have access to a potentially life-changing kidney transplant
The drug is designed to improve functional capacity and reduce symptoms by inhibiting cardiac myosin motor activity
Biocon will be responsible for supplying Semaglutide to Ajanta for exclusive marketing in 23 countries and semi-exclusive marketing in 3 countries across Africa, Middle East and Central Asia
FOP is a rare genetic disorder caused by mutations in the ALK2 kinase
GSK will make most of its inhaled respiratory portfolio and other products available on a direct purchasing platform, offering savings of up to 66%
Emcure becomes the first Indian company to exclusively distribute and commercialise Poviztra, a second brand of Novo Nordisk’s Semaglutide injection for weight management
Additional investments planned to expand the site’s capacity and capabilities to support growing manufacturing programs
Under the agreement, AVT06 is licensed to enter the US market in the fourth quarter of 2026
Subscribe To Our Newsletter & Stay Updated
